Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
…, P Wei, M Qiu, IH Wulur, J Liu, ME Ehsani… - Genome …, 2013 - genome.cshlp.org
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no
effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown…
effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown…
[HTML][HTML] Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
…, X Wang, TP Beyer, WR Bensch, W Li, ME Ehsani… - Journal of lipid …, 2007 - ASBMB
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protease that regulates low
density lipoprotein receptor (LDLR) protein levels. The mechanisms of this action, however, …
density lipoprotein receptor (LDLR) protein levels. The mechanisms of this action, however, …
Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human
…, DM Bender, JJ Lowinger, WK Guo, ME Ehsani… - Drug metabolism and …, 2011 - ASPET
The carboxylesterases (CESs) are a family of serine hydrolases that hydrolyze compounds
containing an ester, amide, or thioester. In humans, two dominant forms, CES1 and CES2, …
containing an ester, amide, or thioester. In humans, two dominant forms, CES1 and CES2, …
Effect of buffer components and carrier solvents on in vitro activity of recombinant human carboxylesterases
ET Williams, ME Ehsani, X Wang, H Wang… - … of pharmacological and …, 2008 - Elsevier
INTRODUCTION: The effects of buffer and substrate solvent conditions on in vitro activity of
carboxylesterases (CE) have not been previously described. Therefore, it is unknown if the …
carboxylesterases (CE) have not been previously described. Therefore, it is unknown if the …
Generation of mutant murine cytomegalovirus strains from overlapping cosmid and plasmid clones
ME Ehsani, TW Abraha, C Netherland-Snell… - Journal of …, 2000 - Am Soc Microbiol
We have developed a cosmid and plasmid system to generate mutant strains of murine
cytomegalovirus (MCMV). The system is based on a series of seven overlapping cosmid clones …
cytomegalovirus (MCMV). The system is based on a series of seven overlapping cosmid clones …
Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry
YQ Chen, DA Yurek, L Yu, H Wang, ME Ehsani… - Analytical …, 2013 - Elsevier
The last step in sphingolipid biosynthesis is the conversion of ceramide (Cer) to sphingomyelin
(SM), which is catalyzed by sphingomyelin synthase (SMS). Two isoforms of SMS have …
(SM), which is catalyzed by sphingomyelin synthase (SMS). Two isoforms of SMS have …
Development of a novel sandwich ELISA for measuring cell lysate ABCA1 protein levels
JS Troutt, WE Alborn, MA Bellinger, KL Cox, ME Ehsani… - Lipids, 2010 - Springer
ATP-binding cassette transporter A-1 (ABCA1) mediates the transfer of cellular cholesterol
to lipid-poor apolipoproteins. Liver X receptors (LXRs) are regulators of cholesterol …
to lipid-poor apolipoproteins. Liver X receptors (LXRs) are regulators of cholesterol …
A novel splicing variant of proprotein convertase subtilisin/kexin type 9
…, Y Zhao, YW Qian, H Wang, A Lin, ME Ehsani… - DNA and cell …, 2008 - liebertpub.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the most recently identified member
of the proprotein convertase family. Genetic and cell biology studies have suggested a …
of the proprotein convertase family. Genetic and cell biology studies have suggested a …
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
Background Past research in population health trends has shown that injuries form a
substantial burden of population health loss. Regular updates to injury burden assessments are …
substantial burden of population health loss. Regular updates to injury burden assessments are …
[HTML][HTML] Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a …
Background Health-care needs change throughout the life course. It is thus crucial to assess
whether health systems provide access to quality health care for all ages. Drawing from the …
whether health systems provide access to quality health care for all ages. Drawing from the …